Cargando…

Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis

INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D). However, there is a need for daily practice tools for identifying those more prone to suffer from these events. We aimed to assess the relationships between nuclear magnetic resonance ((1)H NMR)-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Serés-Noriega, Tonet, Ortega, Emilio, Perea, Verónica, Giménez, Marga, Boswell, Laura, Mariaca, Karla, Font, Carla, Mesa, Alex, Viñals, Clara, Blanco, Jesús, Vinagre, Irene, Pané, Adriana, Esmatjes, Enric, Conget, Ignacio, Amor, Antonio J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981843/
https://www.ncbi.nlm.nih.gov/pubmed/36732434
http://dx.doi.org/10.1007/s13300-023-01372-x
_version_ 1784900195335536640
author Serés-Noriega, Tonet
Ortega, Emilio
Perea, Verónica
Giménez, Marga
Boswell, Laura
Mariaca, Karla
Font, Carla
Mesa, Alex
Viñals, Clara
Blanco, Jesús
Vinagre, Irene
Pané, Adriana
Esmatjes, Enric
Conget, Ignacio
Amor, Antonio J.
author_facet Serés-Noriega, Tonet
Ortega, Emilio
Perea, Verónica
Giménez, Marga
Boswell, Laura
Mariaca, Karla
Font, Carla
Mesa, Alex
Viñals, Clara
Blanco, Jesús
Vinagre, Irene
Pané, Adriana
Esmatjes, Enric
Conget, Ignacio
Amor, Antonio J.
author_sort Serés-Noriega, Tonet
collection PubMed
description INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D). However, there is a need for daily practice tools for identifying those more prone to suffer from these events. We aimed to assess the relationships between nuclear magnetic resonance ((1)H NMR)-based lipidomic analysis and several CVD risk variables (including preclinical carotid atherosclerosis) in individuals with T1D at high risk. METHODS: We included patients with T1D without CVD, with at least one of the following: age ≥ 40 years, diabetic kidney disease, or ≥ 10 years of evolution with another risk factor. The presence of plaque (intima-media thickness > 1.5 mm) was determined by standardized ultrasonography protocol. Lipidomic analysis was performed by (1)H NMR. Bivariate and multivariate-adjusted differences in (1)H NMR lipidomics were evaluated. RESULTS: We included n = 131 participants (49.6% female, age 46.4 ± 10.3 years, diabetes duration 27.0 ± 9.5 years, 47.3% on statins). Carotid plaques were present in 28.2% of the individuals (n = 12, with ≥ 3 plaques). Glucose (HbA1c), anthropometric (body mass index and waist circumference), and insulin resistance-related (fatty liver index and estimated glucose disposal rate) variables were those most associated with (1)H NMR-derived lipidomic analysis (p < 0.01 for all). Regarding preclinical atherosclerosis, sphingomyelin was independently associated with carotid plaque presence (for 0.1 mmol/L increase, OR 0.50 [0.28–0.86]; p = 0.013), even after adjusting for age, sex, hypertension, statin use, mean 5-year HbA1c and diabetes duration. Furthermore, linoleic acid and ω-6 fatty acids remained independently associated with higher plaque burden (≥ 3 plaques) in multivariate models (0.17 [0.03–0.93] and 0.27 [0.07–0.97], respectively; p < 0.05 for both). CONCLUSION: In our preliminary study of individuals with T1D at high risk, several (1)H NMR-derived lipidomic parameters were independently associated with preclinical atherosclerosis. Specifically, ω-6 fatty acids and linoleic acid seem promising for identifying those with higher plaque burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-023-01372-x.
format Online
Article
Text
id pubmed-9981843
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-99818432023-03-04 Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis Serés-Noriega, Tonet Ortega, Emilio Perea, Verónica Giménez, Marga Boswell, Laura Mariaca, Karla Font, Carla Mesa, Alex Viñals, Clara Blanco, Jesús Vinagre, Irene Pané, Adriana Esmatjes, Enric Conget, Ignacio Amor, Antonio J. Diabetes Ther Original Research INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D). However, there is a need for daily practice tools for identifying those more prone to suffer from these events. We aimed to assess the relationships between nuclear magnetic resonance ((1)H NMR)-based lipidomic analysis and several CVD risk variables (including preclinical carotid atherosclerosis) in individuals with T1D at high risk. METHODS: We included patients with T1D without CVD, with at least one of the following: age ≥ 40 years, diabetic kidney disease, or ≥ 10 years of evolution with another risk factor. The presence of plaque (intima-media thickness > 1.5 mm) was determined by standardized ultrasonography protocol. Lipidomic analysis was performed by (1)H NMR. Bivariate and multivariate-adjusted differences in (1)H NMR lipidomics were evaluated. RESULTS: We included n = 131 participants (49.6% female, age 46.4 ± 10.3 years, diabetes duration 27.0 ± 9.5 years, 47.3% on statins). Carotid plaques were present in 28.2% of the individuals (n = 12, with ≥ 3 plaques). Glucose (HbA1c), anthropometric (body mass index and waist circumference), and insulin resistance-related (fatty liver index and estimated glucose disposal rate) variables were those most associated with (1)H NMR-derived lipidomic analysis (p < 0.01 for all). Regarding preclinical atherosclerosis, sphingomyelin was independently associated with carotid plaque presence (for 0.1 mmol/L increase, OR 0.50 [0.28–0.86]; p = 0.013), even after adjusting for age, sex, hypertension, statin use, mean 5-year HbA1c and diabetes duration. Furthermore, linoleic acid and ω-6 fatty acids remained independently associated with higher plaque burden (≥ 3 plaques) in multivariate models (0.17 [0.03–0.93] and 0.27 [0.07–0.97], respectively; p < 0.05 for both). CONCLUSION: In our preliminary study of individuals with T1D at high risk, several (1)H NMR-derived lipidomic parameters were independently associated with preclinical atherosclerosis. Specifically, ω-6 fatty acids and linoleic acid seem promising for identifying those with higher plaque burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-023-01372-x. Springer Healthcare 2023-02-03 2023-03 /pmc/articles/PMC9981843/ /pubmed/36732434 http://dx.doi.org/10.1007/s13300-023-01372-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Serés-Noriega, Tonet
Ortega, Emilio
Perea, Verónica
Giménez, Marga
Boswell, Laura
Mariaca, Karla
Font, Carla
Mesa, Alex
Viñals, Clara
Blanco, Jesús
Vinagre, Irene
Pané, Adriana
Esmatjes, Enric
Conget, Ignacio
Amor, Antonio J.
Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title_full Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title_fullStr Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title_full_unstemmed Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title_short Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis
title_sort nuclear magnetic resonance-based lipidomics in the assessment of cardiometabolic risk in type 1 diabetes: an exploratory analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981843/
https://www.ncbi.nlm.nih.gov/pubmed/36732434
http://dx.doi.org/10.1007/s13300-023-01372-x
work_keys_str_mv AT seresnoriegatonet nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT ortegaemilio nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT pereaveronica nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT gimenezmarga nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT boswelllaura nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT mariacakarla nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT fontcarla nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT mesaalex nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT vinalsclara nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT blancojesus nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT vinagreirene nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT paneadriana nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT esmatjesenric nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT congetignacio nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis
AT amorantonioj nuclearmagneticresonancebasedlipidomicsintheassessmentofcardiometabolicriskintype1diabetesanexploratoryanalysis